Thermo Fisher Launches Next-Gen Chemically Defined Media to Accelerate Scalable Plasmid DNA Production

  New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scien...

December 16, 2025 | Tuesday | News
Minghui Pharma Secures FDA IND Clearance to Launch Global Phase 3 Trials of MHB018A in Thyroid Eye Disease

Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announc...

December 16, 2025 | Tuesday | News
RedHill Biopharma Highlights Opaganib as Potential Add-On Therapy for Venetoclax-Resistant CLL

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CL...

December 16, 2025 | Tuesday | News
J&J’s AKEEGA Wins FDA Approval After Cutting Progression Risk by More Than Half in BRCA2-Mutated mCSPC

Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for AKEEGA® (n...

December 15, 2025 | Monday | News
Enko and Syngenta Advance First-in-Class Fungicide Chemistry to Field Trials

Enko Chem, Inc. announced  that a novel fungicide class of chemistry developed in collaboration with Syngenta Crop Protection has advanced to field ...

December 12, 2025 | Friday | News
China Approves InnoCare’s Breakthrough TRK Inhibitor Zurletrectinib for Adult and Adolescent Solid Tumors

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced that its next-generation TRK inhibitor, zurletrectinib (ICP-72...

December 12, 2025 | Friday | News
Oxford BioTherapeutics and GSK Launch Multi-Year Collaboration to Develop Novel Antibody-Based Cancer Therapies

Collaboration leverages OBT's proprietary OGAP®-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology ta...

December 11, 2025 | Thursday | News
Zydus Lifesciences Partners With Formycon to Commercialize Keytruda Biosimilar FYB206 in North America

Zydus Lifesciences Limited (including its subsidiaries and affiliates), an innovation-led life-sciences company, with an international presence...

December 10, 2025 | Wednesday | News
Akadeum Launches CDMO Alliance With ElevateBio and Charles River as Inaugural Members

Cell therapy manufacturers Charles River and ElevateBio are named as inaugural members Akadeum Life Sciences, the leader in buoyant cell separation, ann...

December 10, 2025 | Wednesday | News
Ginkgo Bioworks Joins Deep Origin To Build ARPA H Funded Computational Drug Safety Platform

Ginkgo Bioworks  announced its partnership with Deep Origin on a 4.5-year project funded by the Advanced Research Projects Agency for Health (ARPA-H...

December 10, 2025 | Wednesday | News
Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Tumor Profiling Program to China

Pillar Biosciences and AstraZeneca announced an expansion of their existing laboratory access program for NGS-based kitted liquid biopsy tumor profi...

December 09, 2025 | Tuesday | News
Convergen Secures $10 Million Seed Financing to Advance Next-Generation Targeted Protein Degradation Therapies

Convergen, a biotech company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, announced th...

December 09, 2025 | Tuesday | News
Kedrion Secures EMA Orphan Drug Designation for Investigational Aceruloplasminemia Therapy

  Kedrion announces that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its investigational treatment for Congenita...

November 28, 2025 | Friday | News
Sanyou Bio and FatiAbGen Forge Strategic Alliance to Accelerate Global Antibody Discovery

  Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a compre...

November 28, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close